![Sanj Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sanj Patel
Gründer bei
Sarcoma Foundation of America
Vermögen: 85 Mio $ am 31.05.2026
Profil
Sanj K.
Patel is the founder of Kiniksa Pharmaceuticals Ltd., founded in 2015, serving as Chairman & Chief Executive Officer.
Mr. Patel is the founder of Sarcoma Foundation of America, founded in 2015, serving as Director.
Current jobs include Chairman & Chief Executive Officer at Kiniksa Pharmaceuticals International Plc since 2024 and President at Kiniksa Pharmaceuticals Corp.
Former jobs include President, Chief Executive Officer & Director at Synageva BioPharma Corp.
from 2008 to 2015; Independent Director at BioCryst Pharmaceuticals, Inc. from 2015 to 2018; Independent Director at Intercept Pharmaceuticals, Inc. from 2014 to 2015; Independent Director at Syros Pharmaceuticals, Inc. from 2016 to 2018; and Head-Global Clinical Research Operations Council at Genzyme Corp.
from 1999 to 2008.
Education includes undergraduate studies at London South Bank University and graduate studies at Ealing Hammersmith & West London College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
2,46 % | 01.06.2026 | 1.137.763 ( 2,46 % ) | 55 Mio $ | 31.05.2026 |
15,25 % | 01.06.2026 | 626.160 ( 15,25 % ) | 30 Mio $ | 31.05.2026 |
Aktive Positionen von Sanj Patel
| Unternehmen | Position | Beginn |
|---|---|---|
Sarcoma Foundation of America
 Sarcoma Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Gründer | 01.01.2015 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Vorstandsvorsitzender | 01.01.2015 |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Präsident | - |
Ehemalige bekannte Positionen von Sanj Patel
| Unternehmen | Position | Ende |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 20.06.2018 |
| SYROS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 14.06.2018 |
| INTERCEPT PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 24.11.2015 |
| SYNAGEVA BIOPHARMA CORP | Vorstandsvorsitzender | 22.06.2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01.01.2008 |
Ausbildung von Sanj Patel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
London South Bank University
 London South Bank University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Sarcoma Foundation of America
Sarcoma Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Ealing Hammersmith & West London College
 Ealing Hammersmith & West London College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Health Technology |
